mRNA |
R428 |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.03 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.03 |
mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.03 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.03 |
mRNA |
PRL-3 Inhibitor I |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.04 |
mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.04 |
mRNA |
bid1870 |
gCSI |
pan-cancer |
AAC |
0.11 |
0.04 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.04 |
mRNA |
simvastatin |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.04 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.04 |